Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Belatacept Immunosuppression Therapy in Post-Transplant Kidney Recipients: Comparison of 4-Week and 8-Week Dosing Intervals

NCT02560558 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT02560558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02560558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Belatacept Immunosuppression Therapy in Post-Transplant Kidney Recipients: Comparison of 4-Week and 8-Week Dosing Intervals
Lead sponsor
Emory University
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2015
Completion date
August 29, 2019
Enrollment
166 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation